论文部分内容阅读
目的 :通过对儿科上呼吸道感染患者的临床试验疗效进行统计分析,探究抗菌药物在儿科上呼吸道感染治疗中的具体临床应用。方法 :选取2013年7月~2015年2月间,在我院儿科确诊为上呼吸道感染的患者共66例,对66例的上呼吸道感染患者进行临床试验治疗,治疗过程中医务人员对患者的各项抗菌药物使用数据进行详细的统计与记录,并开展回顾性分析。结果 :66例上呼吸道感染的患者中,有38人进行了抗菌药物的治疗,抗菌药物的治疗使用率占66例上呼吸道感染患者的57.58%。儿科上呼吸道感染的临床治疗中,抗菌药物的单药使用率为44.74%(17例),抗菌药物的联合使用率为55.26%(21例)。结论:在医务人员的专业指导下,对儿科上呼吸道患者进行抗菌药物的治疗,能满足患儿及其家属对上呼吸道感染症状的疗效需求,并值得在临床治疗中进行广泛推广。
OBJECTIVE: To investigate the clinical efficacy of antimicrobial agents in the treatment of pediatric upper respiratory tract infections through statistical analysis of clinical trials of pediatric upper respiratory tract infections. Methods: From July 2013 to February 2015, 66 cases of upper respiratory tract infection diagnosed in pediatric department of our hospital were selected. 66 cases of upper respiratory tract infection were treated by clinical trial. During the treatment, Various antimicrobial use data for detailed statistics and records, and conduct a retrospective analysis. Results: Among the 66 patients with upper respiratory tract infection, 38 patients were treated with antimicrobial agents, and the usage of antimicrobial agents accounted for 57.58% of 66 patients with upper respiratory tract infection. In the clinical treatment of pediatric upper respiratory tract infection, the single-drug use rate of antibacterials was 44.74% (17 cases), and the combined use of antibacterials was 55.26% (21 cases). Conclusion: Under the guidance of professional medical staff, the treatment of pediatric upper respiratory tract patients with antimicrobial drugs can meet the needs of children and their families on the symptoms of upper respiratory tract infection and deserves to be widely promoted in clinical treatment.